Search research articles
Contact Us
Filters
Showing results (541-550 of 831) with videos related to
Page
of 84
Sort By:
Clinical Genitourinary Cancer
|
October 30, 2016
Prostate Cancer Patients With Unmanaged Diabetes or Receiving Insulin Experience Inferior Outcomes and Toxicities After Treatment With Radiation Therapy
Nicholas G Zaorsky, Talha Shaikh, Karen Ruth, et al.
Issues in Mental Health Nursing
|
March 7, 2014
Screening for symptoms of postpartum traumatic stress in a sample of mothers with preterm infants
Richard J Shaw, Emily A Lilo, Amy Storfer-Isser, et al.
International Journal of Radiation Oncology, Biology, Physics
|
October 1, 1996
Assessing the variability of outcome for patients treated with localized prostate irradiation using different definitions of biochemical control
E M Horwitz, F A Vicini, E L Ziaja, et al.
Cancer
|
April 7, 1998
Treatment outcome with radiation therapy after breast augmentation or reconstruction in patients with primary breast carcinoma
S J Victor, D M Brown, E M Horwitz, et al.
The Canadian Journal of Urology
|
March 7, 2017
The need for androgen deprivation therapy in patients with intermediate-risk prostate cancer treated with dose-escalated external beam radiation therapy
Yanqun Dong, Karen J Ruth, Thomas M Churilla, et al.
Cancer
|
September 1, 1996
Excellent functional outcome in patients with squamous cell carcinoma of the base of tongue treated with external irradiation and interstitial iodine 125 boost
E M Horwitz, A J Frazier, A A Martinez, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 23, 2007
Phase I/II study of an anti-CD30 monoclonal antibody (MDX-060) in Hodgkin's lymphoma and anaplastic large-cell lymphoma
Stephen M Ansell, Steven M Horwitz, Andreas Engert, et al.
Cytotherapy
|
March 14, 2013
Manufacturing mesenchymal stromal cells for phase I clinical trials
Patrick J Hanley, Zhuyong Mei, Maria da Graca Cabreira-Hansen, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
May 1, 2012
Pralatrexate is an effective treatment for relapsed or refractory transformed mycosis fungoides: a subgroup efficacy analysis from the PROPEL study
Francine Foss, Steven M Horwitz, Bertrand Coiffier, et al.
Haematologica
|
March 19, 2026
Non-JAK-family gene fusions in cutaneous T-cell lymphoma highlights genetic diversity and potential therapeutic targets
Robert Stuver, Haiming Tang, Ahmet Dogan, et al.
Page
of 84
Search research articles
Search
Showing results (541-550 of 831) with videos related to
Sort By:
Page
of 84
Clinical Genitourinary Cancer
|
October 30, 2016
Prostate Cancer Patients With Unmanaged Diabetes or Receiving Insulin Experience Inferior Outcomes and Toxicities After Treatment With Radiation Therapy
Nicholas G Zaorsky, Talha Shaikh, Karen Ruth, et al.
Issues in Mental Health Nursing
|
March 7, 2014
Screening for symptoms of postpartum traumatic stress in a sample of mothers with preterm infants
Richard J Shaw, Emily A Lilo, Amy Storfer-Isser, et al.
International Journal of Radiation Oncology, Biology, Physics
|
October 1, 1996
Assessing the variability of outcome for patients treated with localized prostate irradiation using different definitions of biochemical control
E M Horwitz, F A Vicini, E L Ziaja, et al.
Cancer
|
April 7, 1998
Treatment outcome with radiation therapy after breast augmentation or reconstruction in patients with primary breast carcinoma
S J Victor, D M Brown, E M Horwitz, et al.
The Canadian Journal of Urology
|
March 7, 2017
The need for androgen deprivation therapy in patients with intermediate-risk prostate cancer treated with dose-escalated external beam radiation therapy
Yanqun Dong, Karen J Ruth, Thomas M Churilla, et al.
Cancer
|
September 1, 1996
Excellent functional outcome in patients with squamous cell carcinoma of the base of tongue treated with external irradiation and interstitial iodine 125 boost
E M Horwitz, A J Frazier, A A Martinez, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 23, 2007
Phase I/II study of an anti-CD30 monoclonal antibody (MDX-060) in Hodgkin's lymphoma and anaplastic large-cell lymphoma
Stephen M Ansell, Steven M Horwitz, Andreas Engert, et al.
Cytotherapy
|
March 14, 2013
Manufacturing mesenchymal stromal cells for phase I clinical trials
Patrick J Hanley, Zhuyong Mei, Maria da Graca Cabreira-Hansen, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
May 1, 2012
Pralatrexate is an effective treatment for relapsed or refractory transformed mycosis fungoides: a subgroup efficacy analysis from the PROPEL study
Francine Foss, Steven M Horwitz, Bertrand Coiffier, et al.
Haematologica
|
March 19, 2026
Non-JAK-family gene fusions in cutaneous T-cell lymphoma highlights genetic diversity and potential therapeutic targets
Robert Stuver, Haiming Tang, Ahmet Dogan, et al.
Page
of 84